How (and why) do you measure a year in the life? A Practical Guide to Defining Clinical Unmet Need

by Biotech Newsroom


By Julia Pian, Senior Associate at Atlas Venture, as part of the From The Trenches features of LifeSciVC

As Jonathan Larson beautifully explores in “Seasons of Love” from Rent, it’s almost impossible to find the right variables to capture life experiences. Yet frequently in the diligence process, we are trying to understand whether indications like ADA-SCID or CGD have “enough” treatable patients or indications like Heme B or CF have “enough” remaining unmet need given existing therapies to garner venture investment in the early R&D process.

In this post, we will walk through how one integrates key aspects of the patient…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC